These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6477839)

  • 1. Low dose cytosine arabinoside used to induce remission in acute myelofibrosis.
    Whitehead S; Geary CG
    Br J Haematol; 1984 Oct; 58(2):375-6. PubMed ID: 6477839
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment with intermediate dose cytosine arabinoside for myelodysplastic syndrome with acute myelofibrosis.
    Takabayashi M; Sakai R; Kanamori H; Ishigatsubo Y
    Leuk Lymphoma; 2003 May; 44(5):891-2. PubMed ID: 12802934
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of low dose cytosine arabinoside for acute myelofibrosis with immature myeloblast (AML-MO).
    Kanamori H; Tanabe J; Koike T; Hashimoto Y; Matsuzaki M; Kitamura H; Motomura S; Mohri H; Ohkubo T
    Am J Hematol; 1994 Jun; 46(2):154-5. PubMed ID: 8172187
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose cytosine arabinoside therapy in a patient with myelofibrosis during transformation to acute non-lymphocytic leukemia.
    Jensen MK; Johansen P; Ahlbom G
    Acta Med Scand; 1986; 219(1):129-31. PubMed ID: 3953312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Megakaryoblastic leukemia (acute myelofibrosis): complete remission of a case with low-dose cytosine arabinoside].
    Palomera L; García Díez I; Woessner S; Velasco F; Torres A
    Sangre (Barc); 1988 Jun; 33(3):232-7. PubMed ID: 3175820
    [No Abstract]   [Full Text] [Related]  

  • 6. Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes.
    Murray M; Sarsfield P; Lawlor E; McCann SR
    Ir J Med Sci; 1988 Jul; 157(7):238-41. PubMed ID: 3170148
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggressive polychemotherapy for acute myelofibrosis.
    Hertenstein B; Kurrle E; Frickhofen N; Heil G; Heimpel H
    Eur J Haematol; 1990 Apr; 44(4):213-9. PubMed ID: 2344883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis.
    Kobayashi S; Sakai H; Tomiazwa T; Koiso H; Kim K; Ueki K; Tamura J; Yano S; Naruse T; Karasawa M
    J Med; 1999; 30(1-2):101-9. PubMed ID: 10515246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens.
    Zeremski V; Savić A
    Med Pregl; 2014; 67(3-4):83-90. PubMed ID: 24961049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine.
    Lu Q; Chen Y; Li Z
    Leuk Res; 2012 Jun; 36(6):e119-21. PubMed ID: 22386731
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of high-dose cytosine-arabinoside in the treatment of resistant acute leukemia].
    Witz F; Olive D; Lederlin P; Bordigoni P; Troussard X; Grosbois B; Schaison G; Cornu G
    Presse Med; 1987 Feb; 16(4):159-62. PubMed ID: 2950446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose cytosine arabinoside in the consolidation therapy of acute nonlymphocytic leukemia in remission.
    Takaku F; Urabe A; Mizoguchi H; Hoshino S; Toyama K; Tanaka K; Nomura T; Dan K; Fujioka S; Saito T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):55-7. PubMed ID: 3589698
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia.
    Kantarjian HM; Estey EH; Plunkett W; Keating MJ; Walters RS; Iacoboni S; McCredie KB; Freireich EJ
    Am J Med; 1986 Sep; 81(3):387-94. PubMed ID: 3463209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients.
    Tilly H; Castaigne S; Bordessoule D; Sigaux F; Daniel MT; Monconduit M; Degos L
    Cancer; 1985 Apr; 55(8):1633-6. PubMed ID: 3978558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diminished bone marrow fibrosis on autopsy in a patient with acute myelofibrosis following chemotherapy].
    Okada K; Ohsaka A; Tsuboyama A; Takeda K; Sasaki R; Kano Y; Sakamoto S; Hirota N; Miura Y
    Rinsho Ketsueki; 1986 Sep; 27(9):1661-7. PubMed ID: 3806976
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia].
    Ohshima A; Yoshida K; Sato T; Miyazaki S; Yanagisawa M; Nakayama Y; Takahashi T; Mamiya S; Fukusima Y; Miura AB
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):192-5. PubMed ID: 3800405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful remission induction in acute myelomonocytic leukaemia using low-dose cytosine arabinoside following failure of intensive chemotherapy.
    Summerfield GP
    Br J Haematol; 1984 Sep; 58(1):205-7. PubMed ID: 6590090
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis.
    Ngirabacu MC; Ravoet C; Dargent JL; Meuleman N; Ahmad I; Ysebrant L; Bennani J; André M; Bron D
    Haematologica; 2006 Dec; 91(12 Suppl):ECR53. PubMed ID: 17194659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.